Complete Radiologic Response and Long-Term Survival With Use of Systemic High-Dose Methotrexate for Breast Cancer–Associated Leptomeningeal Disease
Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2012.07.010
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2012
Authors
Publisher
Elsevier BV